Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) is a publicly traded Healthcare sector company. As of November 10, 2026, SNOA trades at $1.24 with a market cap of $5.41M and a P/E ratio of -1.00. SNOA moved +0.00% today. Year to date, SNOA is -68.96%; over the trailing twelve months it is -69.04%. Its 52-week range spans $0.85 to $6.92. Rallies surfaces SNOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SNOA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.24 |
| Market Cap | $5.41M |
| P/E Ratio | -1.00 |
| EPS | $-1.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.92 |
| 52-Week Low | $0.85 |
| Volume | 10.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $21.92M |
| Net Income | $-2.26M |
| Gross Margin | 38.91% |
SNOA analyst coverage data. Average price target: $0.00.